Patent details

301359 Product Name: donanemab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301359
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2603523
Status:
SPC granted but not yet in force
Application number:
301359
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/25/1926
Marketing Authorization Type:
EEA
Marketing Authorization Date:
29/09/2025
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
07/01/2026
First Marketing Authorization date:
29/09/2025
Grant date:
10/02/2026
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
07/01/2026
SPC/SPC Extension Expiration Date:
08/08/2036
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
07/01/2026
 
 

 

Name:
ELI LILLY AND COMPANY
Address:
Lilly Corporate Center, 46285, INDIANAPOLIS, INDIANA, United States of America (US)

Agent

Name:
ir. J.C. Volmer c.s.
From:
07/01/2026
Address:
Exter Polak & Charlouis B.V. Postbus 3241, 2280 GE, Rijswijk, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
06/26
Publication date:
11/02/2026
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
02/26
Publication date:
14/01/2026
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/08/2031
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
10/02/2026 Certificate Certificate 1 PDF /6/9/9/0/0/0801200996/docs/301359_10_spcmedcertificate20260210075031111.pdf
10/02/2026 Outgoing Correspondence Decision grant 1 PDF /6/9/9/0/0/0801200996/docs/301359_11_301359695005l504a.pdf
07/01/2026 SPC Documents Summary of the characteristics of the product 19 PDF /6/9/9/0/0/0801200996/docs/301359_0_supplprotectioncertificate20260107034001314.pdf
07/01/2026 SPC Documents Annex SPC 6 PDF /6/9/9/0/0/0801200996/docs/301359_1_supplprotectioncertificate20260107034001350.pdf
07/01/2026 SPC Documents Marketing Authorization SPC 3 PDF /6/9/9/0/0/0801200996/docs/301359_2_supplprotectioncertificate20260107034047580.pdf
07/01/2026 SPC Documents Annex SPC 19 PDF /6/9/9/0/0/0801200996/docs/301359_3_supplprotectioncertificate20260107034001391.pdf
07/01/2026 SPC Documents Annex SPC 11 PDF /6/9/9/0/0/0801200996/docs/301359_4_supplprotectioncertificate20260107033647137.pdf
07/01/2026 SPC Documents Annex SPC 4 PDF /6/9/9/0/0/0801200996/docs/301359_5_supplprotectioncertificate20260107034303279.pdf
07/01/2026 SPC Documents Annex SPC 2 PDF /6/9/9/0/0/0801200996/docs/301359_6_supplprotectioncertificate20260107034127558.pdf
07/01/2026 SPC Documents Accompanying letter SPC 2 PDF /6/9/9/0/0/0801200996/docs/301359_7_supplprotectioncertificate20260107033544461.pdf
07/01/2026 Outgoing Correspondence Confirmation receipt request 2 PDF /6/9/9/0/0/0801200996/docs/301359_8_301359690059l174.pdf
07/01/2026 Application Form First filed application form 2 PDF /6/9/9/0/0/0801200996/docs/301359_9_applicationform20260107033502590.pdf